Results 151 to 160 of about 283,736 (263)
Steatotic liver disease in patients with chronic hepatitis C. [PDF]
Janczura J +6 more
europepmc +1 more source
Pectin, a versatile natural polymer, is extracted through conventional and emerging green extraction methods, offering multifunctional bioactive properties useful in food, pharmaceutical, and environmental applications. ABSTRACT Pectin, a molecular tapestry woven from diverse polysaccharides, holds a pivotal role across food, pharmaceutical, and ...
Afra Anika Rafique +3 more
wiley +1 more source
Observational, Post-marketing Surveillance of Safety and Effectiveness of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C. [PDF]
Lee JW +11 more
europepmc +1 more source
This manuscript reports the findings from the Pharmacogenomic‐guided Antihypertensive Strategy Trial study amidst the deteriorating blood pressure control observed globally during the COVID‐19 pandemic. A pharmacogenomics‐guided strategy achieved a 98.4% blood pressure control rate at 4 weeks in rural China.
Wangjun Qin +22 more
wiley +1 more source
The Effects of Compulsory Licensing: A Case Study of HIV Drugs
ABSTRACT Compulsory licensing is a legal mechanism that allows governments the use of patented medicines without the owner's consent, subject to conditions and compensation, to meet public‐health needs. Despite its policy relevance and increasing use, empirical evidence on its market effects remains limited.
Nicolau Martin‐Bassols +2 more
wiley +1 more source
From Discovery to Cure-Where Are We Now? Mortality Trends in Chronic Hepatitis C: An Analysis of CDC WONDER Database (1999-2023). [PDF]
Ullah A +8 more
europepmc +1 more source
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell +11 more
wiley +1 more source
[Recent Advances in the Treatment of Chronic Hepatitis C]. [PDF]
Kim SB.
europepmc +1 more source
Direct-acting antivirals for chronic hepatitis C infection: a protocol for a systematic review of observational studies. [PDF]
Kumburegama BWMB +10 more
europepmc +1 more source
Chronic hepatitis C: pathological anatomy
Evandro Sobroza de Mello +1 more
doaj +1 more source

